Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check5 days agoChange DetectedAdded related-topic keywords (Multiple myeloma and MedlinePlus Genetics) and updated the site revision from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page's explicit disease label and related resources are removed, reducing the visible context and cross-links to genetics information on this study record.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page's revision label now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a new revision of the page's metadata.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded related topic links for Multiple Myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page no longer includes the primary disease term 'Multiple myeloma' and removes the 'related topics' and 'MedlinePlus Genetics' sections. This reduces the explicit disease context and access to related resources for the study.SummaryDifference0.2%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.